Login / Signup

Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.

Jimin ShiLiqin CaoYi LuoYanmin ZhaoYamin TanJian YuXiaoyu LaiYuanyuan ZhuYongxian HuJingsong HeJie SunWeiyan ZhengGuoqing WeiHe Huang
Published in: Bone marrow transplantation (2020)
Keyphrases
  • tyrosine kinase
  • allogeneic hematopoietic stem cell transplantation
  • acute myeloid leukemia
  • epidermal growth factor receptor
  • low dose
  • peripheral blood
  • acute lymphoblastic leukemia